Men with prostate cancer who are under medical surveillance reported significantly greater resilience and less anxiety after receiving an intervention of mindfulness meditation, a study found. The anxiety and uncertainty that men who...Show More Summary
Marc Cox, Ph.D., associate professor in The University of Texas at El Paso's Department of Biological Sciences, has been selected as the 2016 Texas Inventor of the Year for his treatments for breast and prostate cancer developed at UTEP.
Integration of gene expression and metabolomics data identified key metabolic pathways that are altered in prostate cancer, report scientists at conclusion of their study.
Advanced prostate cancer is usually treated by removing androgen, the male hormone that helps it grow. Although initially effective, this treatment often leads to the tumor becoming castration resistant- a lethal condition. Researchers...Show More Summary
I’M NOT SAYING THIS IS A BAD IDEA, BUT I’M SUSPICIOUS THAT THEY ONLY STARTED TOUTING STUFF LIKE THIS ONCE OBAMACARE PASSED: More Men With Early Prostate Cancer Choosing to Avoid Treatment. Seemingly overnight, treatment of men with early-stage prostate cancer has undergone a sea change. Five years ago, nearly all opted for surgery or […]
Kevin Lomangino is the managing editor of HealthNewsReview.org. He tweets as @klomangino. The New York Times today had a front-page story noting that growing numbers of men diagnosed with prostate cancer are opting for active surveillance of their cancer rather than more aggressive surgery or radiation. Show More Summary
The approach, called active surveillance, involves regular monitoring. Data finds that 40 percent to 50 percent of men are making that choice.
The results are in from the first international clinical trial evaluating the effect of intense physical exercise to improve survival of men with advanced prostate cancer.
Montreal (Quebec), May 24, 2016 - At age 70, Alfred Roberts plays hockey twice a week. Nothing special, right? Except that for three years he has had advanced prostate cancer, which has spread to his bones. "I've always been active. Hockey keeps me in shape and keeps my mind off things. Show More Summary
Myriad Genetics has already provoked ire for its former monopoly on testing for genes associated with breast, ovarian and prostate cancer. The biotechnology company Myriad Genetics is infamous for patenting the BRCA1 and BRCA2 genes—which...Show More Summary
Eight years after an expert task force recommended against routine use of PSA screening for men over 75, testing levels have fallen only slightly.
In obese prostate cancer patients, robotic-assisted surgery to remove the prostate reduces the risk of blood loss and prolonged hospital stays, a Loyola Medicine study has found.
MAYWOOD, IL. -- In obese prostate cancer patients, robotic-assisted surgery to remove the prostate reduces the risk of blood loss and prolonged hospital stays, a Loyola Medicine study has found. The study by senior author Gopal Gupta, MD and colleagues is published in the journal Current Urology. Show More Summary
Prostate cancer is the second leading cause of mortality among American men with the highest incidence rate of all cancers reported in the U.S. Research on this topic was presented at the AAPS National Biotechnology Conference.
The care and management of patients who have been diagnosed with colon and prostate cancer requires a defined multidisciplinary approach. It requires out of the box treatment and an open mind because no two cases or diagnoses are the...Show More Summary
Mutations in BRCA1 and BRCA2 have well-established links to women's diseases -- breast and ovarian cancer. But they also elevate men's health risks, especially for prostate cancer.
Lung cancer kills more people each year than breast, colon, pancreatic and prostate cancer combined. And, every eight minutes, a woman in the United States loses her battle with lung cancer. It's a silent health care crisis that is projected to end the lives of 72,000 American women in 2016 alone - more than a quarter of all female cancer deaths. Show More Summary
Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, but its use can be limited by significant side effects. Researchers from Moffitt Cancer Center report prostate cancer patients who have a variation in the VAC14 gene are more susceptible to a side effect called peripheral neuropathy when treated with the taxane docetaxel.
ANN ARBOR, Mich. -- Remember the game Operation? You need to carefully remove the body part without nicking the sides or the buzzer will sound. Only imagine pulling out the funny bone when it's surrounded by vessels controlling urinary and sexual function. Show More Summary
Tuesday, May 10, 2016, San Diego: A promising new test is detecting prostate cancer more precisely than current tests, by identifying molecular changes in the prostate specific antigen (PSA) protein, according to Cleveland Clinic research...Show More Summary